Pulmonary infections in the athlete

Current Sports Medicine Reports

Volumn 8, Issue 2, 2009, Pages 71-75

  Smoot, M Kyle ^a   Hosey, Robert G ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CIPROFLOXACIN; CLARITHROMYCIN; CORTICOSTEROID; DOXYCYCLINE; GEMIFLOXACIN; LEVOFLOXACIN; MACROLIDE; MOXIFLOXACIN; OSELTAMIVIR; ZANAMIVIR;

ANTIBIOTIC RESISTANCE; ATHLETE; BRONCHITIS; CLINICAL EDUCATION; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; DISEASE SEVERITY; DRUG MEGADOSE; HUMAN; INFECTION RISK; INFLUENZA; LUNG INFECTION; MORTALITY; MYCOSIS; NONHUMAN; REVIEW; SYMPTOMATOLOGY; ACUTE DISEASE; ARTICLE; COMMUNICABLE DISEASE; CONVALESCENCE; FEMALE; LUNG MYCOSIS; MALE; MYCOPLASMA PNEUMONIAE; PATHOGENICITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRACTICE GUIDELINE; RESPIRATORY TRACT INFECTION; RISK ASSESSMENT; SPORT; UNITED STATES;

ACUTE DISEASE; BRONCHITIS; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; GUIDELINES AS TOPIC; HUMANS; LUNG DISEASES, FUNGAL; MALE; MYCOPLASMA PNEUMONIAE; RECOVERY OF FUNCTION; RESPIRATORY TRACT INFECTIONS; RISK ASSESSMENT; SPORTS; UNITED STATES;

EID: 67649335497     PISSN: 1537890X     EISSN: 15378918     Source Type: Journal    
DOI: 10.1249/JSR.0b013e31819c7e87     Document Type: Review

References (38)

1. Braman SS. Chronic cough due to acute bronchitis: ACCP evidencebased clinical practice guidelines. Chest. 2006;129 (1 suppl) :95S-103S.
2. Centers for Disease Control and Prevention (CDC). Severe methicillinresistant Staphylococcus aureus community-acquired pneumonia associated with influenza-Louisiana and Georgia, December 2006-January 2007. Morb. Mortal Wkly. Rep. 2007;56(14):325-9.
3. Chu JH, Feudtner C, Heydon K, Walsh TJ, Zaoutis TE. Hospitalizations for endemic mycoses: a population-based national study. Clin. Infect. Dis. 2006;42(6):822-5.
4. Deeks S, De Serres G, Boulianne N, et al. Failure of physicians to consider the diagnosis of pertussis in children. Clin. Infect. Dis. 1999;28(4):840-6.
5. DeLozier JE, Gagnon RO. National Ambulatory Medical Care Survey: 1989 summary. Adv. Data. 1991;203:1-11.
6. De Roux A, Marcos MA, Garcia E, et al. Viral community-acquired pneumonia in nonimmunocompromised adults. Chest. 2004;125(4):1343-51.
7. Falsey AR, Erdman D, Anderson LJ, Walsh EE. Human metapneumovirus infections in young and elderly adults. J. Infect. Dis. 2003;187(5):785-90.
8. Fine MJ, Singer DE, Hanusa BH, Lave JR, Kapoor WN. Validation of a pneumonia prognostic index using the MedisGroups Comparative Hospital Database. Am. J. Med. 1993;94(2):153-9.
9. Finelli L, Fiore A, Dhara R, et al. Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics. 2008;122(4):805-11.
10. Fiore AE, Shay DK, Broder K, Centers for Disease Control and Prevention (CDC), and the Advisory Committee on Immunization Practices (ACIP). Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 2008;57(RR-7):1-60.
11. Foy HM, Kenny GE, Cooney MK, Allan ID. Long-term epidemiology of infections with Mycoplasma pneumoniae. J. Infect. Dis. 1979;139(6):681-7.
12. Friman G, Ilbäck NG. Acute infection: metabolic responses, effects on performance, interaction with exercise, and myocarditis. Int. J. Sports Med. 1998;19 (Suppl 3) :S172-82.
13. Friman G, Larsson E, Rolf C. Interaction between infection and exercise with special reference to myocarditis and the increased frequency of sudden deaths among young Swedish orienteers 1979-92. Scand. J. Infect. Dis. Suppl. 1997;104:41-9.
14. Gleeson M. Immune function in sport and exercise. J. Appl. Physiol. 2007;103:693-9.
15. Gleeson M. Immune system adaptation in elite athletes. Curr. Opin. Clin. Nutr. Metab. Care. 2006;9(6):659-65.
16. Hallett JS, Jacobs RL. Recurrent acute bronchitis: the association with undiagnosed bronchial asthma. Ann. Allergy. 1985;55(4):568-70.
17. Hammerschlag MR. Mycoplasma pneumoniae infections. Curr. Opin. Infect. Dis. 2001;14(2):181-6.
18. Ilback NG, Fohlman J, Friman G. Exercise in coxsackie B3 myocarditis: effects on heart lymphocyte subpopulations and the inflammatory reaction. Am. Heart J. 1989;117:1298-302.
19. Lorenc TM, Kernan MT. Lower respiratory infections and potential complications in athletes. Curr. Sports Med. Rep. 2006;5(2):80-6.
20. Louie JK, Hacker JK, Gonzales R, et al. Characterization of viral agents causing acute respiratory infection in a San Francisco University Medical Center Clinic during the influenza season. Clin. Infect. Dis. 2005;41(6):822-8.
21. Macfarlane J, Holmes W, Gard P, et al. Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community. Thorax. 2001;56(2):109-14.
22. Malm C. Susceptibility to infections in elite athletes: the S-curve. Scand. J. Med. Sci. Sports. 2006;16:4-6.
23. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clin. Infect. Dis. 2007;44 (suppl 2) :S27-72.
24. Marrie TJ, Beecroft MD, Herman-Gnjidic Z. Resolution of symptoms in patients with community-acquired pneumonia treated on an ambulatory basis. J. Infect. 2004;49(4):302-9.
25. Metlay JP, Fine MJ. Testing strategies in the initial management of patients with community-acquired pneumonia. Ann. Intern. Med. 2003;138(2):109-18.
26. Metlay JP, Fine MJ, Schulz R, et al. Measuring symptomatic and functional recovery in patients with community-acquired pneumonia. J. Gen. Intern. Med. 1997;12(7):423-30.
27. Metlay JP, Kapoor WN, Fine MJ. Does this patient have communityacquired pneumonia? Diagnosing pneumonia by history and physical examination. JAMA. 1997;278(17):1440-5.
28. Nieman DC. Exercise, upper respiratory tract infection, and the immune system. Med. Sci. Sports Exerc. 1994;26(2):128-39.
29. Peiris JS, de Jong MD, Guan Y. Avian influenza virus (H5N1) : a threat to human health. Clin. Microbiol. Rev. 2007;20(2):243-67.
30. Rothberg MB, Haessler SD, Brown RB. Complications of viral influenza. Am. J. Med. 2008;121(4):258-64.
31. Rubinstein E, Kollef MH, Nathwani D. Pneumonia caused by methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis. 2008;46 (suppl 5) :S378-85.
32. Sakoulas G, Moellering RC Jr. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains. Clin. Infect. Dis. 2008;46 (suppl 5) :S360-7.
33. Sutherland ER, Martin RJ. Asthma and atypical bacterial infection. Chest. 2007;132(6):1962-6.
34. Templeton KE, Scheltinga SA, van den Eeden WC, et al. Improved diagnosis of the etiology of community-acquired pneumonia with realtime polymerase chain reaction. Clin. Infect. Dis. 2005;41(3):345-51.
35. Vila-Corcoles A, Ochoa-Gondar O, Rodriguez-Blanco T, Raga-Luria X, Gomez-Bertomeu F, the EPIVAC Study Group. Epidemiology of community-acquired pneumonia in older adults: a population-based study. Respir. Med. 2008 Sep. 17 [Epub ahead of print].
36. Wenzel RP, Fowler AA. Clinical practice. Acute bronchitis. N. Engl. J. Med. 2006;355(20):2125-30.
37. Wheat LJ, Conces D, Allen SD, Blue-Hnidy D, Loyd J. Pulmonary histoplasmosis syndromes: recognition, diagnosis, and management. Semin. Respir. Crit. Care Med. 2004;25(2):129-44.
38. Wheat LJ. Diagnosis and management of histoplasmosis. Eur. J. Clin. Microbiol. Infect. Dis. 1989;8(5):480-90.